David F. Burgstahler

Companies

• OmniAb, Inc.Board member Aug 9, 2021 to Jun 21, 2024¹
• RVL Pharmaceuticals plcBoard member Oct 18, 2018 to Jan 30, 2023²
• OmniAb, Inc.Chief executive officer Aug 9, 2021 to Aug 9, 2021¹
• OmniAb, Inc.President Aug 9, 2021 to Aug 9, 2021¹
• Organogenesis Holdings Inc.Board member Oct 15, 2018 to May 18, 2021³
• WideOpenWest, Inc.Board member May 24, 2017 to Aug 6, 2019⁴
• Organogenesis Holdings Inc.Chief executive officer Dec 12, 2018 to Dec 12, 2018⁵
• Organogenesis Holdings Inc.President Dec 12, 2018 to Dec 12, 2018⁵
• Organogenesis Holdings Inc.Officer Nov 1, 2018 to Nov 1, 2018⁶
• Lantheus Holdings, Inc.Board member Jun 24, 2015 to Sep 11, 2017⁷
• Syneos Health, Inc.Board member Nov 6, 2014 to May 24, 2017⁸
• ANGIODYNAMICS INCBoard member May 23, 2012 to Apr 14, 2017⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OOmniAb, Inc. OABIW15,835,704 shares¹⁰$2.7M at $0.17Nov 1, 2023
• RPRVL Pharmaceuticals plc23,730,864 shares¹¹Jan 30, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 1, 2023Exercised options 17,770 shares of OmniAb, Inc.¹⁰
• Jan 27, 2023Other 1,032,995 shares of RVL Pharmaceuticals plc¹¹
• Dec 9, 2022Other 8,534,450 shares of OmniAb, Inc.¹²
• Dec 9, 2022Other 7,283,484 shares of OmniAb, Inc.¹²
• Dec 9, 2022Other 15,817,934 shares of OmniAb, Inc.¹²
• Nov 1, 2022Granted 10,172,934 shares at $10.00 of OmniAb, Inc.¹³
• Aug 8, 2022Bought 8,000,000 shares at $1.55 of RVL Pharmaceuticals plc¹⁴